profession

JAMA changes editorial policy on trial-data analysis

NEWS IN BRIEF — Posted July 15, 2013

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Journal of the American Medical Association has ended its policy that required industry-sponsored clinical trial data be reviewed by an independent academic statistician. The policy was adopted in 2005 after a rash of controversies in which drugmakers hid, omitted or dishonestly manipulated unfavorable trial data, but no other major medical journals followed suit.

In a June 20 editorial, JAMA Editor-in-Chief Howard Bauchner, MD, detailed the decision. “JAMA will evaluate and consider for publication clinical trials that are analyzed by statisticians employed by or contracted by the study sponsor, without requiring independent statistical analysis by an academic biostatistician,” Dr. Bauchner wrote. “Advances over the past decade in standards of clinical trial reporting, enhanced understanding of the threats to validity of clinical research, increasing data transparency, and our experience support the change in policy.”

Dr. Bauchner added that the policy had “been perceived by some in academia and industry as creating barriers to publication of important trial results.” He noted that in the two years since he took over as editor-in-chief, analyses conducted by academic statisticians did not typically lead to “meaningful changes” in study results.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story